Comments

Codexis Stock Price, Quotes and Forecasts

Q: What sector and industry does Codexis (CDXS) operate in?

Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

CDXSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.35

At close: May 29 EDT

$2.36

0.010000.43%

Pre-Market: 7:11 PM EDT

Codexis (CDXS) Forecast

News Earnings Codexis (CDXS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Codexis Stock Price, Quotes and Forecasts | NASDAQ:CDXS | Benzinga

Explore Codexis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CDXS.

Open	-
Close	-
Volume / Avg.	0 / 1.02M
Day Range	- - -
52 Wk Range	1.90 - 6.08
Market Cap	$195.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.04%
Days to Cover	8.98

Recent News

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Avi Kapoor

Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough

Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).

Akanksha Bakshi

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.02M
Day Range	- - -
52 Wk Range	1.90 - 6.08
Market Cap	$195.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.04%
Days to Cover	8.98

About Codexis Inc.

Sector

Health Care

Industry

Life Sciences Tools & Services

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Codexis (CDXS) stock?

You can purchase shares of Codexis (NASDAQ:CDXS) through any online brokerage.

View our list of the best stock brokerages

Who are Codexis (CDXS) competitors?

Other companies in Codexis’s space includes: Harvard Bioscience (NASDAQ:HBIO), Lifecore Biomedical (NASDAQ:LFCR), Quanterix (NASDAQ:QTRX), Conduit Pharmaceuticals (NASDAQ:CDT) and Cytek Biosciences (NASDAQ:CTKB).

What is the forecast, or price target, for Codexis (CDXS) stock?

Codexis has a consensus price target of $12.67.

What is the current price for Codexis (CDXS)?

The stock price for Codexis (NASDAQ: CDXS) is $2.36 last updated May 29, 2025 at 7:11 PM EDT.

Does Codexis (CDXS) pay a dividend?

There are no upcoming dividends for Codexis.

When is Codexis (NASDAQ:CDXS) reporting earnings?

Codexis’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Codexis (CDXS) going to split?

There is no upcoming split for Codexis.

What sector and industry does Codexis (CDXS) operate in?

Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.